Will Quist | Snailmail (by Slow Ventures)

Will Quist

Jan 25, 2026

3 min read
AI's First Big Victims
Why the cybersecurity oligarchs are the most vulnerable

Dec 20, 2025

3 min read
Closing Thoughts for 2026
There’s a real shift in how early-stage capital is deployed. Seed rounds used to be about testing ideas with a little optionality. Now, they’re $10–20M “seed” rounds before anyone knows what the product is.

Dec 12, 2025

2 min read
AI Missed Its Punk Rock Moment (Or Did It?)
AI is supposed to be a paradigm shift—something that shatters assumptions and rewires the system. But right now, it feels less like punk rock and more like enterprise software on steroids.

Nov 28, 2025

2 min read
Stop Chasing Hot Rounds, Earn Your Conviction First
There’s a lot of noise in the market right now—hot rounds, frothy multiples, “move fast” energy everywhere. But the real signal? The founders who take their time, develop deep conviction, and only then commit.

Nov 23, 2025

2 min read
Oceans: The Most Fragile Layer of the Global Economy
We’re living in an era where maritime infrastructure is the invisible backbone of modern economies. It’s easy to forget, but subsea communications cables now carry 99% of all internet traffic.

Nov 18, 2025

2 min read
Venture’s Dirty Secret: Nobody Wants to Price Your Round
This is a signal about how risk is being managed (or avoided) at the top of the venture stack. Rather than price discovery or real diligence, we’re seeing a herd mentality: “Just show me the evidence to justify a markup, and I’m in.

Nov 2, 2025

3 min read
AI Is Breaking the Cybersecurity Oligopoly
We’re in the middle of an inflection point. For twenty years, cloud-based security vendors have eaten the lunch of their client-server predecessors. But AI—specifically LLMs and agentic adversarial agents—breaks the mold.

Oct 25, 2025

3 min read
The IBM-ification of Venture Is In Full Swing
The big market signal is that capital is finally flowing into hard tech and deep tech. But here's the twist, it's still early. Outside of defense, most of these categories are pre-consensus, pre-signal, and most investors are still risk-off.

Oct 16, 2025

3 min read
Capital Is Not a Badge, It’s a Drug. Use Only as Directed.
Venture capital is powerful medicine. But too many founders treat it like a default prescription—have an idea, make a deck, raise a round. That’s backwards. You don’t start with the drug; you start with the diagnosis.

Sep 18, 2025

3 min read
Experienced Founders Need Slow Conviction Over Fast Momentum
When your alternative is a $500K+ a year in cash and RSUs, sprinting toward incorporation becomes expensive. Once you incorporate, you're working on this for three years minimum. That's at least $1.5M in opportunity cost.

Aug 13, 2025

2 min read
Lets Build Robots That Eat the World
As with most hard tech, the cost of building groundbreaking robots often outweighs their ability to deliver real returns. However, there is one pricing model that already exists — and it may unlock the true economics for Robot-as-a-Service to work.